|
Weight-loss
drug has dual benefits for type 2s.
(In the Pipeline) Diabetes Forecast v51, n11 (Nov 1998): 35 (3 pages).COPYRIGHT
1998 American Diabetes Association Inc.
Hoffmann-LaRoche,
which makes orlistat, funded the study. The company expects to fulfill
the requirements for final FDA approval during the first quarter of
1999.Aronne, Louis J. Modern medical management
of obesity: the role of pharmaceutical intervention.Journal
of the American Dietetic Association v98 n10 (Oct, 1998):S23 (4 pages).COPYRIGHT
1998 American Dietetic Association
Drug
Development Fat Blocker Anti-Obesity Drug Launched in United Kingdom.World
Disease Weekly Plus (Oct 5, 1998):NA.Copyright 1998 Charles W Henderson
Mulrow,
Cynthia D.Helping an obese patient make informed choices. (Clinical
Review) British Medical Journal v317, n7153 (July 25, 1998): 266 (2
pages).Copyright 1998 British Medical Association (U.K.)
Work
Janis A.. Exercise for the overweight patient.Physician
and Sportsmedicine v18, n7 (July, 1990): 113 (2 pages).
Wadden,
Thomas A.; Van Itallie, Theodore B.; Blackburn, George L.Responsible
and irresponsible use of very-low-calorie diets in the treatment of obesity,
JAMA, The Journal of the American Medical Association v263, nl (Jan 5,
1990):83 (2 pages).
Apgar,
Barbara Does Weight Loss Plus Exercise Improve Insulin Sensitivity?American
Family Physician v59, n6 (March 15, 1999):1641 (1 pages).COPYRIGHT 1999
American Academy of Family Physicians
Weight-loss
News That's Easy to Stomach. University
Diet & Nutrition Letter v14, n2 (April, 1996):1 (1 pages).COPYRIGHT
Tufts University Diet and Nutrition Letter 1996
Bovsun,
Mara The Diet Dilemma. (includes related articles) (Cover Story)
Medical World News v33, n5 (May, 1992):17 (6 pages).COPYRIGHT
Medical Tribune Inc. 1992
|